Manufacturing, Corporate Finance


InSilica, Inc.

in
InSilica, Inc. announced that it has received $6 million in second round of funding on February 19, 2008. The round saw participation from existing investors Flextronics International Ltd., Crossbow Ventures Inc., and Intel Capital.
 

OccuLogix Inc.

in
OccuLogix Inc. announced that it has secured a bridge loan in an aggregate principal amount of $3,000,000 from a number of private parties. The loan bears interest at a rate of 12% per annum and will have a 180-day term, which may be extended to 270 days under certain circumstances. The repayment of the loan is secured by a pledge by the Company of its 50.1% ownership interest in OcuSense Inc. OcuSense Inc.

Insite Vision Inc

in
Insite Vision Inc. announced that it has closed a private placement to institutional investors of $60 million in aggregate principal amount of non-convertible, non-recourse promissory notes. The notes are secured by royalties to be paid from sales in the United States and Canada of AzaSite(R) (azithromycin ophthalmic solution) 1%, a drug licensed to and sold by Inspire Pharmaceuticals for the topical treatment of bacterial conjunctivitis (pink eye).

Syndicate content